PharmExec Direct:
Having trouble viewing this e-mail? Click here.
May 24, 2012 | ISSUE NUMBER 252 VOL 8
Physician Incentives Show Me The Money
A new report from ZS Associates explores the efficacy and impact of physician incentive compensation on the delivery of quality care; when incentives fall short, so can patient outcomes...Read more
Advertisement Establishing Case Quality Metrics - defining and using quality metrics for adverse event case processing.
Measurement of case quality in pharmacovigilance is a relatively new development. Until pharmaceutical companies began outsourcing their case processing operations, the only measure of effectiveness of their internal operations was compliance with regulatory reporting timelines. Now that these operations are performed by vendors, over the last two years vendor management organizations within pharmaceutical companies and Health Authorities have come up with a way to measure the "quality" of Adverse Event (AE) cases. This paper captures our experience and learning in defining and using case quality metrics while working with large and small pharmaceutical companies. http://www.sciformix.com/Establishing.php
World Health Assembly Will WHO Member States Pony Up for Neglected Diseases?
The World Health Organization asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest countries; the group’s conclusions are under discussion at this week’s World Health Assembly ...Read More
Advertisement
Adam Smith Conferences' Russian Pharmaceutical Forum (22-24 May, St. Petersburg, Russia) - the biggest industry event of the year, with over 500 senior executives representing all the leading international and local pharmaceutical companies, distributors, retail chains, gathering to attend to discuss all the burning questions of the day, to compare experiences and share ideas for the future. Get involved – REGISTER TO ATTEND athttps://www.adamsmithconferences.com/hr21pebw
Advertisement The Basics of the Sunshine Act and the Implications for Your Business.
GLive Webcast: Tuesday, June 12, 2012 at 2:00PM EDT http://www.pharmexec.com/basics
// Pfizer promoted Olivier Brandicourt to president and general manager of the company's emerging markets and established products business units. He succeeds David Simmons, who is leaving to head a CRO. Brandicourt, a member of the Pfizer Executive Leadership Team, most recently served as president and general manager of the primary care business unit. // Healthcare Data Solutions appointed Jim Stahl to senior vice president of sales. Stahl has previously worked at life sciences agencies including M3 Health and Physicians Interactive, and in pharma, at Wyeth and Rhone-Poulenc Rorer, among other companies. // Covidien promoted Gregory Andrulonis to vice president and treasurer. Andrulonis succeeds Kevin DaSilva, who will remain VP, group chief financial officer. Andrulonis comes from Tyco International; Covidien separated from Tyco in 2007 and became an independent company. // PSI, a full-service contract research organization, hired Oscar Podesta as head of Latin America. Podesta holds a degree in biochemistry from the Universidad de Buenos Aires, and was previously general manager, Latin America, at Chiltern International.
Advertisement Optimizing R&D Spending at Hospira
Live Webcast: Wednesday, June 20, 2012 at 01:00 PM EDT
Register Free at http://www.pharmexec.com/hospira
